Smadar Kleinstein
Family Medicine · Clifton, NJNPI 1962443366
Payments from drug & device makers
Across 181 payments — averaging $13.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$674
- AbbVie$657
- AstraZeneca$321
- Lilly USA, LLC$171
- Exact Sciences$107
- Takeda Pharmaceuticals U.S.A., Inc.$105
- plus $488 from 18 others
What the payments were for
- Food & beverage$2,49099%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 46 | $674 |
| AbbVie | 59 | $657 |
| AstraZeneca | 21 | $321 |
| Lilly USA, LLC | 11 | $171 |
| Exact Sciences | 5 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $105 |
| Pfizer | 5 | $82 |
| Idorsia Pharmaceuticals US Inc | 4 | $57 |
| Merck | 3 | $49 |
| Boehringer Ingelheim | 3 | $48 |
| Astellas Pharma US Inc | 2 | $35 |
| Amgen | 2 | $29 |
| Amarin Pharma, Inc. | 2 | $28 |
| Qiagen, LLC | 1 | $21 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Althera Pharmaceuticals LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Bausch Health US, LLC | 1 | $15 |
| Mirum Pharmaceuticals, Inc. | 1 | $15 |
| Boston Scientific | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| GSK | 1 | $13 |
| Dexcom, Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$108
How this compares
$2,522 in reported general payments places this provider in the 80th percentile of 2,084 family medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 38 | $34,489 |
| MounjaroTirzepatide | 26 | $28,704 |
| EliquisApixaban | 25 | $26,521 |
| JardianceEmpagliflozin | 22 | $26,415 |
| JanumetSitagliptin Phos/Metformin Hcl | 13 | $15,306 |
| FarxigaDapagliflozin Propanediol | 18 | $11,331 |
| SynthroidLevothyroxine Sodium | 13 | $1,546 |
| Rosuvastatin Calcium | 72 | $1,204 |
| Levothyroxine Sodium | 104 | $929 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $766 |
| Atorvastatin Calcium | 112 | $762 |
| Pantoprazole Sodium | 35 | $541 |
| Lisinopril | 52 | $518 |
| Sertraline Hcl | 40 | $511 |
| Esomeprazole Magnesium | 12 | $487 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $674 | $34,48938 claims |
| Lilly USA, LLCMounjaro | $171 | $28,70426 claims |
| PfizerEliquis | $82 | $26,52125 claims |
| Boehringer IngelheimJardiance | $48 | $26,41522 claims |
| MerckJanumet | $49 | $15,30613 claims |
| AstraZenecaFarxiga | $321 | $11,33118 claims |
| AbbVieSynthroid | $657 | $1,54613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,084 family medicine providers in New Jersey.
Other family medicine in Clifton
- Michael DobrowClifton$2.1M
- Samir KhalilClifton$40K
- Anna PudinakClifton$20K
- Vikram GuptaClifton$15K
- Howard HassmanClementon$47.1M
- Matthew HongNorth Cape May$15.3M
- Rubaba HussainClark$3.8M
- Gaurang BrahmbhattHoboken$2.6M
- Mikhail VarshavskiChatham$1.4M
- Amit BhalodiaCamden$707K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.